Reply to: Yttrium-90 Radioembolization Provides Durable Local Control and Definitive Radiation Therapy

Christopher H. Crane

Department of Radiation Oncology, Memorial Sloan Kettering Cancer Center, New York, NY

Theodore S. Hong

Dana-Farber Cancer Institute and Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, MA

Freddy E. Escorcia

Christopher H. Crane, MD, Department of Radiation Oncology, Memorial Sloan Kettering Cancer Center, New York, NY; Theodore S. Hong, MD, FASCO, Harvard Medical School, Boston, Massachusetts; Freddy E. Escorcia, MD, PhD, Laboratory of Molecular Radiotherapy, National Institutes of Health, Bethesda, MD; and Laura A. Dawson, MD, Department of Radiation Oncology, University of Toronto, Toronto, Canada, Radiation Medicine Program, Princess Margaret Cancer Centre, University Health Network, Toronto, Canada

Laura A. Dawson

Radiation Medicine Program, Princess Margaret Cancer Centre, University Health Network, Toronto, ON, Canada